What is Osteoporosis?
Osteoporosis is the most common metabolic disease of the bones. In this disease the amount of mineral and organic substances are adequately decreased. Osteoporosis is a type of disease that the bones became weak and frangible in it and the risk of frangibility will increase.
Osteoporosis is defined as reduction in the bone mineral density (BMD) by which the power of bones is reduced and they became fragile, also the possibility of frangibility will rise. Osteoporosis gradually develops and it shows no sign until the fracture happens.
The following factors play roles in the maximum amount of the bone mineral density:
- Genetic factors
- Physical activity
Osteoporosis happens in both men and women by getting older, but in women it will be intensified as a result of interruption in producing the estrogen by the age of menopause.
Also following long-period utilization of some medications like Corticosteroids and being afflicted with some diseases like Hyperthyroidism, Coeliac and hyperparathyroidism will raise the risk of Osteoporosis affliction in the person too.
Osteoporosis is a silent disease. That is; usually it remains with no sign until the person refers to the doctor due to a pain or fraction.
The possibility of Osteoporosis emergence will increase by getting older. Since the maximum of bone mineral density happens from the ages 30 to 35 years old, it would be necessary to use dietary supplements like Calcium – Vitamin D3 and Silicon, etc. in order to prevent Osteoporosis especially after these years.
Because of global spread, the disease of Osteoporosis is considered as a relevant factor to the public health. It is estimated that there are more than 200 millions of people suffering from this disease all around the world. Through the studies done by the Ministry of Health in Iran it shows that 47% of women and 44% of men who has more than 50 years old are suffering from bone compaction deficiency and also 6.4% of people under 20 to 70 years are suffering from backbone Osteoporosis in Iran. Among each of 4 Iranian women, one of them is afflicted with the Osteoporosis.
The effect of Osvalin on Osteoporosis:
The available silicon in the Osvalin increases the amount of collagen type 1 production that is available in the texture of the bones. By increasing the collagen in the texture of bones, a harder bone will be created and the restoration of bone fraction will be raised. Also the density of organic and mineral substances will be increased by this medication (mineralization).
Osvalin will boost the activity of osteoblast cells and reduce the activity of osteoclast ones. Therefore, it plays an important role in the formation of the bones.
Through the accomplished investigations, it is recorded that the people who use more than 40 milligrams of silicon per day have 10 percent of bone mineral density in comparison to the ones who receive less than 14 milligrams of silicon.
In another investigation, it is illustrated that by raising the amount of silicon from 15 to 45 milligrams per day, the bone mineral density will have a considerable growth in both men and women.
Other researches have shown that having the Calcium and Vitamin D3 together with silicon in the diet has an eye-catching effect on the bone density advancement in comparison to singly having Calcium and Vitamin D3 in the diet.
In addition to the role of bone and cartilage tissue protection, the existing Vitamin C in the Osvalin pack has a positive effect on increasing the silicon absorption.
In an investigation on 100 pelvis fraction, it showed that the people who use more Vitamin C per day had less pelvis fraction in comparison to the ones who receive lesser amounts.
Also the laboratory tests have shown that Vitamin C triggers the development of collagen production.
All along these evidences, Osvalin helps in preventing the Osteoporosis and treating it by having silicon dioxide 15%, magnesium 315 and Vitamin C. Also it aids in the rapid restoration of fractions and bone surgeries.